Showing results (311-320 of 363) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|November 10, 2009
Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamicsLynn Rozenberg, Bart L Haagmans, Avidan U Neumann, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2010
Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine responseY Rotman, B B Borg, A Soza, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patientsVeronique Nussenblatt, Mary McLaughlin, Catherine A Rehm, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Plos One|March 11, 2011
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphismsMartin Lagging, Galia Askarieh, Francesco Negro, et al.
Cell|May 22, 2020
Paleolithic to Bronze Age Siberians Reveal Connections with First Americans and across EurasiaHe Yu, Maria A Spyrou, Marina Karapetian, et al.
Journal of Hepatology|February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.
The Journal of Infectious Diseases|September 9, 2006
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infectionAna I Romero, Martin Lagging, Johan Westin, et al.
Allergy|January 21, 2022
Differential effects of lung inflammation on insulin resistance in humans and miceRuth Karlina, Claudia Flexeder, Stephanie Musiol, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Pageof 37